CMHRJ
  • Register
  • Login
##common.pageHeaderLogo.altText##
  • Home
  • About
    • About the Journal
    • Author Guideline
    • Open access
    • Publication Charges
    • Indexing
    • Copyright Form
    • Plagiarism policy
    • Copyright policy
    • Privacy Statement
    • Digital archiving policy
    • Publication Ethics
    • Review Process
  • Editorial Team
  • Current
  • Archives
  • Submissions
  • Manuscript Template
  • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 2 No. 3 (2022): May - June
  4. Articles

Vol. 2 No. 3 (2022)

May 2022

Human T-Cell Lymphotropic Virus-1 Causing Diseases and Cancer in Human

  • Mohammad Salim
  • Mohammad Shahid Masroor
  • Shagufta Parween

Clinical Medicine And Health Research Journal, Vol. 2 No. 3 (2022), 10 May 2022 , Page 132-135
https://doi.org/10.18535/cmhrj.v2i3.49 Published 10 May 2022

  • View Article
  • Download
  • Cite
  • Reference
  • Statastics
  • Share

Abstract

Human T-cell leukaemia virus-1(HTLV-1) is a kind of retrovirus which after entering in the human body reversely transcribed into several proviruses integrating the host genome develops a lethal blood cancer known as adult T-cell leukaemia (ATL). HTLV-1 also develops some other life threatening diseases like HTLV-1 associated myelopathy or tropical spastic myelopathy (HAM/TSP) in human. The present paper is an attempt to discuss discovery, epidemiology, diagnosis and transmission of the virus with their diseases and cancer causing abilities in the light of recent researches done so far in the field of microbial origin of cancer.

    PDF

How to Cite

Salim, M. ., Masroor, M. S. ., & Parween, S. . (2022). Human T-Cell Lymphotropic Virus-1 Causing Diseases and Cancer in Human. Clinical Medicine And Health Research Journal, 2(3), 132–135. https://doi.org/10.18535/cmhrj.v2i3.49
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver

  • Download Citation

    • Endnote/Zotero/Mendeley (RIS)
    • BibTeX

    References

  • Ishitasuka K, Tamura K . Human T-cell leukaemia virus type 1 and adult T-cell leukaemia –lymphoma. Lancet Oncol. 2014; 15:517-526.
  • McKendall RR. Neurologic disease due to HTLV-1 infection . Handb. Clin. Neurol. 2014;123:507-530
  • Charles RMB , Lee Ratner. How does HTLV-1 cause adult T-cell leukaemia / lymphoma(ATL) ? Curr.Opin.Virol.2015;14:93-100.
  • Oliveira PD , Kachimarek AC, Biitencourt AL . Early onset of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell leukaemia / lymphoma (ATL) : systematic search and review .J. Trop. Pediatr. 2018;64:151-161.
  • Poiesz BJ, Ruscetti FW , Reitz MS , Robert C. Isolation of a new type of C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia. Nature 1981;294(5838) : 268-271. doi : 10.1038/294268a0.
  • Verdonck K, Gonzalez E, Van DS, Gotuzzo E. Human T-lymphotropic virus-1 : Recent knowledge about an ancient infection . The Lancet Infectious Dieases 2007 ; 7(4) : 266-281 . doi:10.1016/S1473-3099(07) 70081-6.
  • Gonclaves DU, Proietti FA, Pinhiro SR, Proittic ABF. Epidemiology, treatment and prevention of human T-cell leukemia virus type- 1 associated diseases . Clinical Microbiology Reviews 2010;23(3):577-589.
  • Chihara D, Ito-H , Katanoda-K, Tajima K. Increase in incidence of adult T-cell leukaemia/lymphoma in non-endemic areas of Japan and the United States . Cancer Science 2012;103(10):1857-1860.
  • Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors . J . Med. Virol . 2012 ; 84(2): 327-335.
  • Nosaka K, Iwanaga M, Imaizumi Y, Ishida Y. Epidemiological and clinical features of adult T-cell leukaemia –lymphoma in Japan , 2010-2011:a nationwide survey. Cancer Sci. 2017;108:2478-2486.
  • Anat M, Hiroko Y, Michi M, Birney E, Charles RMB . The human leukaemia virus HTLV-1 alters the structure and transcription of host chromatin in cis. eLife 2018; Doi: 10. 7554/eLife.36245.
  • Araujo AQC. Update on neurological manifestations of HTLV-1 infection. Curr. Infect. Dis.Rep.2015;17:459.doi:10.1007/s 11908-014-0459-0.
  • Oliveira de, Neto JAC , Andrade RCP, Rocha PN . Risk factors for erectile dysfunction in men with HTLV-1 . J. Sex. Med.2017;14:1195-1200.
  • Lopes MAL, Rios GMF, Lacerda AJP, Paixao TS. Human T-lymphotropic virus-1 associated myelopathy/tropical spastic paraparesis is associated with sexual dysfunction in infected woman of reproductive age . Sex.Med.2018;6(4):324-331.
  • Gotuzzo E, Moody J, Verdonck K, Cabada MM ,Gonzalez E. Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis of strongyloidiasis. Panam.Salud.Publica.2007;22:223-230.
  • Silva da JL, Rita PJR, Oliveira MFS , Farre L. Clustering of HTLV-1 associated myelopathy /tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil. J. Clin.Virol. 2013;58:482-485.doi.10.1016/ j.jcv.2013.07.012.
  • Bigger RJ, Kim N ,Hisada M, Li H, Cranston B. Human leucocyte antigen concordance and the transmission risk via breast feeding of human T-cell lymphotropic virus type 1. J.Infect.Dis.2006;193:277-282.doi:10.1086/948910.
  • Amor MM, Olaso AS, Cohen S, Kossev P. Adult T-cell leukaemia/lymphoma during pregnancy . Case Rep. Oncol. Med. 2013;631825. doi :10.1155/2013/631825.
  • Percher F, Jeannin P, Gessain A , Afonso PV . Mother to child transmission of HTLV-1 epidemiological aspects, mechanisms and determinants of mother –to-child transmission. Viruses 2016;8:E40.doi:10.3390/v/8020040.
  • Nicot C. Current views in HTLV-1 associated adult T-cell leukaemia/lymphoma. Am.J. Hematol. 2005; 78(3): 232 -239. doc:10.1002/ajh.20307.
  • Matsuoka M and Jeang K. Human T-cell leukaemia virus type-1 (HTLV-1) infectivity and cellular transformation . Nature Reviews Cancer 2007; 7(4): 270-280.
  • Marneros A, Grossman M, Sivers D, Connor O. Pralatrexate –induced tumor cell apoptosis in the dermis of patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions. Blood 2009 ; 113 (25): 6338-6341.
  • Subramaniam J, Whiteside G, McKeage K, Croxtall J. Mogamulizumab: first global approval. Drugs 2012;72(9): 1293-1298.
    • Article Viewed: 50 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    • Linkedin
    • Twitter
    • Facebook
    • Telegram

    Cover Image

    Information

    • For Readers
    • For Authors
    • For Librarians
    • Home
    • Archives
    • Submissions
    • About the Journal
    • Editorial Team
    • Contact
     Open Access Policy || Publication & Peer Review Policy || Publication Ethics
    The publication is licensed under a Creative Commons License (CC BY). View Legal Code
     Clinical Medicine And Health Research Journal
    Clinical Medicine and Health Research Journal (CMHRJ)